Rice, A., Verma, M., Voigt, E., Battisti, P., Beaver, S., Reed, S., . . . Soon-Shiong, P. (2022, July). Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies. Frontiers in Immunology.
Chicago Style (17th ed.) CitationRice, Adrian, et al. "Heterologous SaRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies." Frontiers in Immunology Jul. 2022.
MLA (9th ed.) CitationRice, Adrian, et al. "Heterologous SaRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies." Frontiers in Immunology, Jul. 2022.
Warning: These citations may not always be 100% accurate.